• Connect with us
  • Information
    • About Us
    • Contact Us
    • Careers
    • Partnerships
    • Advertise With Us
    • Authors
    • Browse Topics
    • Events
    • Disclaimer
    • Privacy Policy
  • Australia
    North America
    World
Login
Investing News NetworkYour trusted source for investing success
  • North America
    Australia
    World
  • My INN
Videos
Companies
Press Releases
Private Placements
SUBSCRIBE
  • Reports & Guides
    • Market Outlook Reports
    • Investing Guides
  • Button
Resource
  • Precious Metals
  • Battery Metals
  • Base Metals
  • Energy
  • Critical Minerals
Tech
Life Science
Cleantech Market
Cleantech News
Cleantech Stocks
  • Cleantech Market
  • Cleantech News
  • Cleantech Stocks
cleantech investing

MyDx Reports First Quarter Results

Written by Jocelyn Aspa
|
May. 23, 2017 08:28AM PST

MyDx (OTCQB:MYDX) has announced its Q1 results together with its management analysis. As quoted in the press release: Financial ResultsRevenue and client deposits increased to ~$264k, up ~50% from the same quarter in the previous year, on strong product & licensing demand  Revenue was lifted by increasing demand for CannaDx™ Sensor, which in turn was …

MyDx (OTCQB:MYDX) has announced its Q1 results together with its management analysis.
As quoted in the press release:

Financial Results
Revenue and client deposits increased to ~$264k, up ~50% from the same quarter in the previous year, on strong product & licensing demand

  •  Revenue was lifted by increasing demand for CannaDx™ Sensor, which in turn was brought on by greater consumer awareness of MyDx products and services
  • MyDx sold out of its signature Handheld Analyzer on stronger than expected demand leading to a backlog of orders and customer deposits that are currently being filled

For the first time in company history, the company is cash-flow positive with ~$30k in operating cash flows vs. (~$210k) from the same quarter in the previous year

  • The company demonstrated its ability to generate sufficient positive cash flow to maintain and grow its core business operations
  • Combined with cash flows from investing and financing activities, the company generated net positive cash flow of ~$100k, which strengthened the overall balance sheet by increasing cash on hand to ~$135k
  • The company intends to make substantial investments in marketing and sales to grow the business and execute on its growth strategy, which may impact cash-flow characteristics going forward

Satisfied ~$250k in debt used to finance company operations and support growth initiatives

  • The company continued its march to relieve itself of toxic variable rate debt obligations, which has significantly reduced its yearly debt burden and brought a level of stability to the stock price.

Click here to read the full press release.

cleantech investing financial results
The Conversation (0)

Go Deeper

AI Powered

KORU Medical Systems Announces 27% Q3 Revenue Growth and Raises 2025 Revenue Guidance

MP Materials Reports Second Quarter 2025 Results

MP Materials Reports Second Quarter 2025 Results

Latest News

Outlook Reports world

Resource
  • Precious Metals
    • Gold
    • Silver
  • Battery Metals
    • Lithium
    • Cobalt
    • Graphite
  • Energy
    • Uranium
    • Oil and Gas
  • Base Metals
    • Copper
    • Nickel
    • Zinc
  • Critical Metals
    • Rare Earths
  • Industrial Metals
  • Agriculture
Tech
    • Artificial Intelligence
    • Cybersecurity
    • Gaming
    • Cleantech
    • Emerging Tech
Life Science
    • Biotech
    • Cannabis
    • Psychedelics
    • Pharmaceuticals

Featured Cleantech Investing Stocks

Homerun Resources

HMR:CC

Carbonxt Group

Carbonxt Group (CG1:AU)
CG1:AU

Provaris Energy

Provaris Energy (PV1:AU)
PV1:AU

NEO Battery Materials

NEO Battery Materials (NBM:CC)
NBM:CC

Frontier Energy

Frontier Energy (FHE:AU)
FHE:AU

Carbon Done Right

Carbon Done Right (KLX:CC)
KLX:CC
More featured stocks

Browse Companies

Resource
  • Precious Metals
  • Battery Metals
  • Energy
  • Base Metals
  • Critical Metals
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES